重庆市卫健委回应相关医院为患儿注射疑似失效药情况

Core Viewpoint - The Chongqing Municipal Health Commission has initiated an investigation into the Chongqing Medical University Affiliated Children's Hospital regarding allegations of administering potentially ineffective medication to a patient with spinal muscular atrophy [1] Group 1: Investigation and Findings - A special investigation team was formed to verify the claims about the hospital's practices [1] - Initial findings revealed that the medication, Nusinersen, was improperly stored, as it should have been kept between 2°C and 8°C and not frozen [1] - The involved physician will face serious consequences for the violation of medication storage protocols [1] Group 2: Patient Care and Response - The patient, diagnosed with spinal muscular atrophy type II, was admitted on December 9, 2025, and discharged the following day without adverse reactions noted during the treatment [1] - The health commission is prioritizing the protection of patient health and is organizing expert consultations to assess the impact of the improper medication storage on the patient's condition [1] - A revised treatment plan will be developed to ensure the patient receives appropriate care [1] Group 3: Future Actions - The Chongqing Municipal Health Commission will continue to investigate the situation thoroughly and enhance medical quality and safety supervision [1] - There will be a focus on standardizing medical personnel's diagnostic and treatment behaviors to prevent future violations in medical services [1]